The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway
Open accessAbstract
Public health measures successfully contained outbreaks of the severe acute respiratory syndrome coronavirus (SARS-CoV) infection. However, the precursor of the SARS-CoV remains in its natural bat reservoir, and reemergence of a human-adapted SARS-like coronavirus remains a plausible public health concern. Vaccination is a major strategy for containing resurgence of SARS in humans, and a number of vaccine candidates have been tested in experimental animal models. We previously reported that antibody elicited by a SARS-CoV vaccine candidate based on recombinant full-length Spike-protein trimers potentiated infection of human B cell lines despite eliciting in vivo a neutralizing and protective immune response in rodents. These observations prompted us to investigate the mechanisms underlying antibody-dependent enhancement (ADE) of SARS-CoV infection in vitro. We demonstrate here that anti-Spike immune serum, while inhibiting viral entry in a permissive cell line, potentiated infection of immune cells by SARS-CoV Spike-pseudotyped lentiviral particles, as well as replication-competent SARS coronavirus. Antibody-mediated infection was dependent on Fcγ receptor II but did not use the endosomal/lysosomal pathway utilized by angiotensin I converting enzyme 2 (ACE2), the accepted receptor for SARS-CoV. This suggests that ADE of SARS-CoV utilizes a novel cell entry mechanism into immune cells. Different SARS vaccine candidates elicit sera that differ in their capacity to induce ADE in immune cells despite their comparable potency to neutralize infection in ACE2-bearing cells. Our results suggest a novel mechanism by which SARS-CoV can enter target cells and illustrate the potential pitfalls associated with immunization against it. These findings should prompt further investigations into SARS pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Self-citationPrimer3Plus, an enhanced web interface to Primer3
Untergasser, A., Nijveen, H., Rao, X., Bisseling, T., Geurts, R., & Leunissen, J. A. M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm306 · Cited by 2,779
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y., Tsoi, H.-W., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K.-H., & Yuen, K.-Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,544
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Daëron, M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.203 · Cited by 1,227
Self-citationLung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,052
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., Laman, J. D., de Jong, T., van Doornum, G., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,020
Self-citationQuantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
Harmer, D., Gilbert, M., Borman, R., & Clark, K. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03640-2 · Cited by 852
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K., & Nabel, G. J. (2004) · Nature · doi:10.1038/nature02463 · Cited by 665
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 605
Virus membrane-fusion proteins: more than one way to make a hairpin
Kielian, M., & Rey, F. A. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1326 · Cited by 570
Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306446101 · Cited by 543
Yang, Z.-Y., Huang, Y., Ganesh, L., Leung, K., Kong, W.-P., Schwartz, O., Subbarao, K., & Nabel, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5642-5650.2004 · Cited by 490
Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells
Law, H. K. W., Cheung, C. Y., Ng, H. Y., Sia, S. F., Chan, Y. O., Luk, W., Nicholls, J. M., Peiris, J. S. M., & Lau, Y. L. (2005) · Blood · doi:10.1182/blood-2004-10-4166 · Cited by 471
Self-citationFc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.
Salmon, J. E., Millard, S., Schachter, L. A., Arnett, F. C., Ginzler, E. M., Gourley, M. F., Ramsey-Goldman, R., Peterson, M. G., & Kimberly, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118552 · Cited by 469
Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S.-F., Wu, M. H. S., Chan, K.-H., Yuen, K.-Y., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461
Self-citationCo-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells
Lanier, L. L., Yu, G., & Phillips, J. H. (1989) · Nature · doi:10.1038/342803a0 · Cited by 432
Recognition of viruses by cytoplasmic sensors
Wilkins, C., & Gale, M. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.12.003 · Cited by 430
Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Buchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
Huang, I.-C., Bosch, B. J., Li, F., Li, W., Lee, K. H., Ghiran, S., Vasilieva, N., Dermody, T. S., Harrison, S. C., Dormitzer, P. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508381200 · Cited by 375
Weingartl, H., Czub, M., Czub, S., Neufeld, J., Marszal, P., Gren, J., Smith, G., Jones, S., Proulx, R., Deschambault, Y., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12672-12676.2004 · Cited by 344
Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications
Takada, A., & Kawaoka, Y. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.405 · Cited by 332
Molecular basis for a polymorphism of human Fc gamma receptor II (CD32).
Warmerdam, P. A., van de Winkel, J. G., Gosselin, E. J., & Capel, P. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.19 · Cited by 298
Vennema, H., de Groot, R. J., Harbour, D. A., Dalderup, M., Gruffydd-Jones, T., Horzinek, M. C., & Spaan, W. J. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1407-1409.1990 · Cited by 277
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
Yang, Z.-Y., Werner, H. C., Kong, W.-P., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 253
Chen, J., & Subbarao, K. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141706 · Cited by 251
Kuhn, J. H., Li, W., Choe, H., & Farzan, M. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-004-4242-5 · Cited by 249
Innate immune responses to influenza A H5N1: friend or foe?
Peiris, J. S. M., Cheung, C. Y., Leung, C. Y. H., & Nicholls, J. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.09.004 · Cited by 232
Self-citationRottier, P. J. M., Nakamura, K., Schellen, P., Volders, H., & Haijema, B. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14122-14130.2005 · Cited by 229
Fredericksen, B. L., Wei, B. L., Yao, J., Luo, T., & Garcia, J. V. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11440-11446.2002 · Cited by 211
Kam, Y. W., Kien, F., Roberts, A., Cheung, Y. C., Lamirande, E. W., Vogel, L., Chu, S. L., Tse, J., Guarner, J., Zaki, S. R., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.011 · Cited by 210
Self-citationHofmann, H., Hattermann, K., Marzi, A., Gramberg, T., Geier, M., Krumbiegel, M., Kuate, S., Überla, K., Niedrig, M., & Pöhlmann, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6134-6142.2004 · Cited by 199
SARS-coronavirus replication in human peripheral monocytes/macrophages
Yilla, M., Harcourt, B. H., Hickman, C. J., McGrew, M., Tamin, A., Goldsmith, C. S., Bellini, W. J., & Anderson, L. J. (2005) · Virus Research · doi:10.1016/j.virusres.2004.09.004 · Cited by 190
Zhang, L., Zhang, F., Yu, W., He, T., Yu, J., Yi, C. E., Ba, L., Li, W., Farzan, M., Chen, Z., et al. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20499 · Cited by 186
Roper, R. L., & Rehm, K. E. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.43 · Cited by 180
Olsen, C. W., Corapi, W. V., Ngichabe, C. K., Baines, J. D., & Scott, F. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.956-965.1992 · Cited by 179
Activation of host pattern recognition receptors by viruses
Brennan, K., & Bowie, A. G. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.007 · Cited by 178
Vaccine-induced enhancement of viral infections
Huisman, W., Martina, B. E. E., Rimmelzwaan, G. F., Gruters, R. A., & Osterhaus, A. D. M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.10.087 · Cited by 172
The SARS-Unique Domain (SUD) of SARS Coronavirus Contains Two Macrodomains That Bind G-Quadruplexes
Tan, J., Vonrhein, C., Smart, O. S., Bricogne, G., Bollati, M., Kusov, Y., Hansen, G., Mesters, J. R., Schmidt, C. L., & Hilgenfeld, R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000428 · Cited by 169
Law, P. T. W., Wong, C.-H., Au, T. C. C., Chuck, C.-P., Kong, S.-K., Chan, P. K. S., To, K.-F., Lo, A. W. I., Chan, J. Y. W., Suen, Y.-K., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.80813-0 · Cited by 165
Neutralizing Antibody Response and SARS Severity
Ho, M., Chen, W., Chen, H., Lin, S.-F., Wang, M.-C., Di, J., Lu, Y., Liu, C., Chang, S., Chao, C.-L., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1111.040659 · Cited by 144
Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008) · Journal of Virology · doi:10.1128/jvi.02377-07 · Cited by 134 · cited 1×
“In contrast, another group, using panels of isogenic SARS-CoV, did not find any evidence of infection enhancing potential with a series of monoclonal antibodies (50).”
ResultCorapi, W. V., Olsen, C. W., & Scott, F. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6695-6705.1992 · Cited by 129
Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis
Sawicki, S. G., & Sawicki, D. L. (1986) · Journal of Virology · doi:10.1128/jvi.57.1.328-334.1986 · Cited by 126
Wei, B. L., Denton, P. W., O’Neill, E., Luo, T., Foster, J. L., & García, J. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5705-5712.2005 · Cited by 122
Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
Lee, N. L. S., Chan, P. K. S., Ip, M., Wong, E., Ho, J., Ho, C., Cockram, C. S., & Hui, D. S. C. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.07.005 · Cited by 121
Clinical Relevance of Fcγ Receptor Polymorphisms
Rascu, A., Repp, R., WESTERDAAL, N. A. C., Kalden, J. R., & van de Winkel, J. G. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52070.x · Cited by 119
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
Enjuanes, L., DeDiego, M. L., Álvarez, E. A., Deming, D., Sheahan, T., & Baric, R. S. (2007) · Virus Research · doi:10.1016/j.virusres.2007.01.021 · Cited by 119
Letourneur, O., Kennedy, I. C. S., Brini, A. T., Ortaldo, J. R., O’Shea, J. J., & Kinet, J.-P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2652 · Cited by 110
The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function
Chan, C.-M., Tsoi, H., Chan, W.-M., Zhai, S., Wong, C., Yao, X., Chan, W. Y., Tsui, S. K., & Chan, H. Y. E. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.019 · Cited by 102
SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients
Li, L., Wo, J.-E., Shao, J., Zhu, H., Wu, N., Li, M., Hangpin, Y., Hu, M., & Dennin, R. H. (2003) · Journal of Clinical Virology · doi:10.1016/s1386-6532(03)00195-1 · Cited by 98
Hohdatsu, T., Yamada, M., TOMINAGA, R., MAKINO, K., Kida, K., & Koyama, H. (1998) · Journal of Veterinary Medical Science · doi:10.1292/jvms.60.49 · Cited by 97
Influence of FcγRIIA and MBL polymorphisms on severe acute respiratory syndrome
Yuan, F. F., Tanner, J. A., Chan, P. K. S., Biffin, S., Dyer, W. B., Geczy, A. F., Tang, J. W.-T., Hui, D. S. C., Sung, J. J. �., & Sullivan, J. S. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00476.x · Cited by 91
Nefkens, I., Garcia, J., Ling, C. S., Lagarde, N., Nicholls, J. M., Tang, D. J., Peiris, M. J. S., Buchy, P., & Altmeyer, R. M. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.02.005 · Cited by 90
Self-citationAnimal coronavirus vaccines: lessons for SARS.
Saif, L. J. (2004) · PubMed · Cited by 87
Gillim-Ross, L., Taylor, J., Scholl, D. R., Ridenour, J., Masters, P. S., & Wentworth, D. E. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3196-3206.2004 · Cited by 81
Antibody-Mediated Enhancement of Viral Disease
Sullivan, N. J. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_8 · Cited by 79
A novel role for the Fc receptor gamma subunit: enhancement of Fc gamma R ligand affinity.
Miller, K. L., Duchemin, A., & Anderson, C. L. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2227 · Cited by 79
Palmer, P., Charley, B., Rombaut, B., Daëron, M., & Lebon, P. (2000) · Virology · doi:10.1006/viro.2000.0627 · Cited by 65
Self-citationFridman, W. H., Teillaud, J., Bouchard, C., Teillaud, C., Astier, A., Tartour, É., Galon, J., Mathiot, C., & Sautès‐Fridman, C. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.5.504 · Cited by 65
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
David, A., Sáez‐Cirión, A., Versmisse, P., Malbec, O., Iannascoli, B., Herschke, F., Lucas‐Hourani, M., Barré‐Sinoussi, F., Mouscadet, J. F., Daëron, M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6291 · Cited by 34
Self-citationPark, S., Sestak, K., Hodgins, D. C., Shoup, D. I., Ward, L., Jackwood, D. J., & Saif, L. J. (1998) · American Journal of Veterinary Research · doi:10.2460/ajvr.1998.59.08.1002 · Cited by 30
Callendret, B., Lorin, V., Charneau, P., Marianneau, P., Contamin, H., Betton, J., van der Werf, S., & Escriou, N. (2007) · Virology · doi:10.1016/j.virol.2007.01.012 · Cited by 21
Self-citationSautès‐Fridman, C. (1997) · Springer eBooks · doi:10.1007/978-1-4613-1181-2_6 · Cited by 15
Cited by
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
“Some antibodies against SARSCoV-1 Spike mediate antibody-dependent enhancement (ADE) of infection in vitro and exacerbate disease in animal models (Jaume et al., 2011; Wan et al., 2020; Wang et al., 2014; Yip et al., 2016).”
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Viral targets for vaccines against COVID-19
Dai, L., & Gao, G. F. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00480-0 · Cited by 1,048
Myocarditis With COVID-19 mRNA Vaccines
Bozkurt, B., Kamat, I., & Hotez, P. J. (2021) · Circulation · doi:10.1161/circulationaha.121.056135 · Cited by 806
Rapid COVID-19 vaccine development
Graham, B. S. (2020) · Science · doi:10.1126/science.abb8923 · Cited by 771
Metadata
- Authors
- Jaume, M., Yip, M. S., Cheung, C. Y., Leung, H. L., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R., Nal, B., Daëron, M., Bruzzone, R., & Peiris, J. S. M.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2011-10-15
- Volume
- 85
- Issue
- 20
- Pages
- 10582-10597
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2113391111
- Cited by
- 314
- References
- 72
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.